Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Emanuel Raymond"'
Autor:
Lewis, Emanuel Raymond
Publikováno v:
Military Affairs, 1964 Oct 01. 28(3), 111-122.
Externí odkaz:
https://www.jstor.org/stable/1985345
Autor:
Lewis, Emanuel Raymond
Publikováno v:
Warship International, 1976 Jan 01. 13(4), 276-303.
Externí odkaz:
https://www.jstor.org/stable/44890454
Autor:
Rina Kashi, Aric Orbach, Victor Piryatinsky, Daphna Laifenfeld, Mark A. Ator, Tal Birnberg, Doron Shinar, Tal Hingaly, Efrat Rubinstein, Emanuel Raymond, Einat Amit-Romach, Fadi Towfic, Ralph Laufer, Yael Marantz, Iris Grossman, Joel Kaye, Ignacio S. Caballero, Volker Knappertz, Michael R. Hayden
Publikováno v:
Proceedings of the National Academy of Sciences. 113
Laquinimod is an oral drug currently being evaluated for the treatment of relapsing, remitting, and primary progressive multiple sclerosis and Huntington’s disease. Laquinimod exerts beneficial activities on both the peripheral immune system and th
Autor:
Ramona Pförtner, Sara W. Feigelson, Emanuel Raymond, Christine Stadelmann, Wolfgang Brück, Bracha Timan, Liat Hayardeny, Christiane Wegner, Ronen Alon
Publikováno v:
Journal of Neuroimmunology. 227:133-143
We investigated the effect of laquinimod on inflammatory demyelination, axonal damage, cytokine profiles and migratory capacities of lymphocytes in C57BL/6 mice with active EAE induced with MOG(35-55) peptide. The mice were treated at disease inducti
Autor:
Ety Klinger, Rona Shofti, Arthur Malley, Ruth Arnon, Michael Sela, Emanuel Raymond, Dvora Teitelbaum, Rivka Kreitman, Rina Aharoni
Publikováno v:
Annals of the New York Academy of Sciences. 1029:239-249
Glatiramer acetate (GA, Copaxone, copolymer 1) for injection is an approved drug for relapsing-remitting multiple sclerosis. The clinical and immunological effects of GA were extensively studied in experimental autoimmune encephalomyelitis (EAE), the
Publikováno v:
Neurology. 78:P04.142-P04.142
Objective: Studying whether laquinimod treatment added on top of either GA (glatiramer acetate) or IFNb would result in an additive effect on disease severity in MOG-induced EAE. Background Laquinimod is an orally administered CNS-active immunomodula
Autor:
Ritchie, Elspeth Cameron, Cassimatis, Emmanuel, Emanuel, Raymond, Milliken, Charles, Gray, Sheila Hafter
Publikováno v:
Journal of the American Academy of Psychoanalysis & Dynamic Psychiatry; Dec2003, Vol. 31 Issue 4, p663-673, 11p
Autor:
Lewis, Emanuel Raymond
Publikováno v:
The Pennsylvania Magazine of History and Biography, 1971 Jan 01. 95(1), 128-129.
Externí odkaz:
https://www.jstor.org/stable/20090524
Autor:
Lewis, Emanuel Raymond
Publikováno v:
Military Affairs, 1966 Dec 01. 30(3), 162-163.
Externí odkaz:
https://www.jstor.org/stable/1985374
Autor:
Emanuel Raymond Lewis, Ian V. Hogg
Publikováno v:
Military Affairs. 35:36